Friedemann Paul, MD, Charité-Universitätsmedizin Berlin, Berlin, Germany, describes the first attempt to propose diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). An international panel developed the newly proposed criteria, highlighting how MOG-IgG cell-based assays are important for diagnostic accuracy and should meet specific quality benchmarks. These proposed diagnostic criteria are now being validated across various patient cohorts. This interview took place at the American Academy of Neurology Annual Meeting 2023 in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.